Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Eirik, Tjønnfjord"'
Publikováno v:
Thrombosis Journal, Vol 22, Iss 1, Pp 1-7 (2024)
Abstract A 28-year-old man diagnosed with triple positive antiphospholipid syndrome (APS) and undergoing warfarin experienced three separate admissions to the cardiac ward within a one-month period due to escalating chest pain. While the initial two
Externí odkaz:
https://doaj.org/article/f01d9700fbf54e6482ed012547ee47ea
Autor:
Ekaterina Ilicheva, Eirik Tjønnfjord, Riccardo Tomasello, Heidi Pettersen, Hoa Tran, Galina Tsykonova, Lamya Garabet, Geir Tjønnfjord, Waleed Ghanima
Publikováno v:
HemaSphere, Vol 7, p e28425f8 (2023)
Externí odkaz:
https://doaj.org/article/814b2403fd8d406c8780c641e44adc6c
Autor:
Camilla Tøvik Jørgensen, Mazdak Tavoly, Heidi Hassel Pettersen, Eli Førsund, Christina Roaldsnes, Magnus Kringstad Olsen, Eirik Tjønnfjord, Jostein Gleditsch, Aleksandra Grdinic Galovic, Synne Frønæs Vikum, Sigrid Kufaas Brækkan, Waleed Ghanima
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 5, Pp n/a-n/a (2022)
Abstract Purpose The incidence of venous thromboembolism (VTE) is expected to increase over the next decades, further increasing its substantial impact on patients and health care resources. Registries have the benefit of reporting real‐world data
Externí odkaz:
https://doaj.org/article/c596d421ebb64119b44ffdd06613a6f0
Autor:
Magdalena R. Værnesbranden, Eirik Tjønnfjord, Prabhu Murugaiah, Vilde Victoria Løgavlen, Line Norman Kvenshagen, Ai Phi Thuy Ho, Lars Prag Antonsen, Kari Holte, Ingunn Kristoffersen
Publikováno v:
Tidsskrift for Den norske legeforening.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b000da68f4cbf358aab15b5886f3ef9
https://doi.org/10.4045/tidsskr.22.0282
https://doi.org/10.4045/tidsskr.22.0282
Autor:
Marc Michel, Eirik Tjønnfjord, Abderrahim Khelif, Waleed Ghanima, Bernadette Darne, Neila Ben Romdhan, Pål Andre Holme, Anders Waage
Publikováno v:
British Journal of Haematology
RITP was a double‐blind randomized, 78‐week follow‐up trial in which 109 adults with immune thrombocytopenias (ITP) who failed to achieve adequate response to steroids, were randomized to receive rituximab or placebo. Here, we provide the durat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4903394ee2da0a451b200c6ab909bfc4
https://doi.org/10.1111/bjh.16672
https://doi.org/10.1111/bjh.16672
Autor:
Lamya, Garabet, Anna, Eriksson, Eirik, Tjønnfjord, Xue-Yan, Cui, Magnus Kringstad, Olsen, Hege Karine, Jacobsen, Camilla Tøvik, Jørgensen, Åse-Berit, Mathisen, Marie-Christine, Mowinckel, Maria Therese, Ahlen, Ingvild Hausberg, Sørvoll, Kjersti Daae, Horvei, Siw Leiknes, Ernstsen, Ingvild Jenssen, Lægreid, Benedicte, Stavik, René, Holst, Per Morten, Sandset, Waleed, Ghanima
Background: SARS-CoV-2 adenoviral vector DNA vaccines have been linked to the rare but serious thrombotic postvaccine complication vaccine-induced immune thrombotic thrombocytopenia. This has raised concerns regarding the possibility of increased thr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f5f12bb44af7ba702666d9034e5b98e
https://hdl.handle.net/10037/28790
https://hdl.handle.net/10037/28790
Publikováno v:
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 141(10)
Since the beginning of the pandemic we have learned much about acute organ complications due to COVID-19, but we are still only beginning to understand the post-infection complications.A man in his forties was diagnosed with subacute thyroiditis afte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dd019a22456fa2d7f57c7f0cc8cfb115
https://pubmed.ncbi.nlm.nih.gov/34182720
https://pubmed.ncbi.nlm.nih.gov/34182720
Autor:
Lamya Garabet, Siri Øverstad, Synne G. Fronas, Eirik Tjønnfjord, Jonas Bergan, Saad Aballi, Waleed Ghanima
Publikováno v:
Thrombosis Research
• We report four non-hospitalized COVID-19 patients who developed VTE in their course of illness. • None of our patients had major risk factors for developing VTE. • A secondary respiratory worsening of COVID-19 should prompt investigation for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8306773e9b74aace6041a0580f38b1c6
https://doi.org/10.1016/j.thromres.2020.06.032
https://doi.org/10.1016/j.thromres.2020.06.032
Autor:
Anne Marie Halstensen, Renathe Henriksen Grønli, Siw Leiknes Ernstsen, Ingvild Hausberg Sørvoll, Svetlana Lund, Ingvild Jenssen Lægreid, Anna Eriksson, Kjersti Daae Horvei, Waleed Ghanima, Magnus Kringstad Olsen, Eirik Tjønnfjord, Hege Karine Jacobsen, Maria Therese Ahlen
Publikováno v:
Journal of Thrombosis and Haemostasis
Background The COVID‐19 vaccine from AstraZeneca (AZD1222) is one of several vaccines introduced to provide immunity against SARS‐CoV‐2. Recently, more than 50 cases have been reported presenting a combination of thrombosis, thrombocytopenia, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff9bdeb6375588482927e9f37b1f2ed0
http://hdl.handle.net/10852/87361
http://hdl.handle.net/10852/87361
Publikováno v:
Tidsskrift for Den norske legeforening.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f8d49cb0350a901e31b1bd7a34f520b
https://doi.org/10.4045/tidsskr.21.0169
https://doi.org/10.4045/tidsskr.21.0169